中国药物与临床
中國藥物與臨床
중국약물여림상
CHINESE REMEDIES & CLINICS
2014年
6期
732-735
,共4页
田伟%武飚%张章%贺杰峰%赵浩亮
田偉%武飚%張章%賀傑峰%趙浩亮
전위%무표%장장%하걸봉%조호량
急性重症,急性胰腺炎%中性白细胞%细胞凋亡%乌司他丁
急性重癥,急性胰腺炎%中性白細胞%細胞凋亡%烏司他丁
급성중증,급성이선염%중성백세포%세포조망%오사타정
Pancreatitis,acute necrotizing%Neutrophils%Apoptosis%Ulinastatin
目的:探讨重症急性胰腺炎(SAP)大鼠外周血中性粒细胞凋亡的变化及乌司他丁对不同凋亡通路的影响。方法健康Wistar大鼠90只随机分为3组:假手术组(SHAM组,30只)、SAP模型组(SAP组,30只)和乌司他丁治疗组(ULi组,30只)。大鼠经十二指肠乳头逆行注射3.5%牛黄胆酸钠诱导构建SAP模型;ULi组同法诱导构建SAP模型后,经门静脉给予乌司他丁50000 U/kg;SHAM组开腹仅翻动胰腺和十二指肠。各组于术后0、3、6、12和24 h分批处死大鼠,切取胰腺组织,采集下腔静脉血。对各组不同时点大鼠胰腺组织进行胰腺组织病理学评分,测定血清淀粉酶,并分离中性粒细胞进行凋亡检测及Caspase1、3和8活性的检测。结果SAP组各时点胰腺组织病理学评分、血清淀粉酶水平及Caspase1活性明显高于SHAM组和ULi组(P<0.05),外周中性粒细胞凋亡率、Caspase3和8明显低于ULi组。结论中性粒细胞凋亡在SAP的病程及转归中发挥重要作用;乌司他丁对Caspase 3和8的活性有影响,可以显著减轻胰腺病理损伤,改善SAP预后。
目的:探討重癥急性胰腺炎(SAP)大鼠外週血中性粒細胞凋亡的變化及烏司他丁對不同凋亡通路的影響。方法健康Wistar大鼠90隻隨機分為3組:假手術組(SHAM組,30隻)、SAP模型組(SAP組,30隻)和烏司他丁治療組(ULi組,30隻)。大鼠經十二指腸乳頭逆行註射3.5%牛黃膽痠鈉誘導構建SAP模型;ULi組同法誘導構建SAP模型後,經門靜脈給予烏司他丁50000 U/kg;SHAM組開腹僅翻動胰腺和十二指腸。各組于術後0、3、6、12和24 h分批處死大鼠,切取胰腺組織,採集下腔靜脈血。對各組不同時點大鼠胰腺組織進行胰腺組織病理學評分,測定血清澱粉酶,併分離中性粒細胞進行凋亡檢測及Caspase1、3和8活性的檢測。結果SAP組各時點胰腺組織病理學評分、血清澱粉酶水平及Caspase1活性明顯高于SHAM組和ULi組(P<0.05),外週中性粒細胞凋亡率、Caspase3和8明顯低于ULi組。結論中性粒細胞凋亡在SAP的病程及轉歸中髮揮重要作用;烏司他丁對Caspase 3和8的活性有影響,可以顯著減輕胰腺病理損傷,改善SAP預後。
목적:탐토중증급성이선염(SAP)대서외주혈중성립세포조망적변화급오사타정대불동조망통로적영향。방법건강Wistar대서90지수궤분위3조:가수술조(SHAM조,30지)、SAP모형조(SAP조,30지)화오사타정치료조(ULi조,30지)。대서경십이지장유두역행주사3.5%우황담산납유도구건SAP모형;ULi조동법유도구건SAP모형후,경문정맥급여오사타정50000 U/kg;SHAM조개복부번동이선화십이지장。각조우술후0、3、6、12화24 h분비처사대서,절취이선조직,채집하강정맥혈。대각조불동시점대서이선조직진행이선조직병이학평분,측정혈청정분매,병분리중성립세포진행조망검측급Caspase1、3화8활성적검측。결과SAP조각시점이선조직병이학평분、혈청정분매수평급Caspase1활성명현고우SHAM조화ULi조(P<0.05),외주중성립세포조망솔、Caspase3화8명현저우ULi조。결론중성립세포조망재SAP적병정급전귀중발휘중요작용;오사타정대Caspase 3화8적활성유영향,가이현저감경이선병리손상,개선SAP예후。
Objective To explore the changes in polymorphonuclear neutrophils (PMN) and the effects of uli-nastatin on different biomarker signaling pathways in rats with severe acute pancreatitis (SAP). Methods Ninty healthy Wistar rats were randomly allocated to Sham group (n=30), SAP group (n=30) and ulinastatin (ULi) group (n=30). The SAP rat model was induced by 3.15%sodium taurocholate retrograde injection to the common biliopancreatic ducts via the papilla duodeni. Following establishment of the SAP rat model, rats in group ULi were treated with uli-nastatin 50 000 U/kg through portal vein injection. Pancreas and duodenum were only flipped after opening the ab-dominal cavity in Sham group. Rats were sacrificed at 0, 3, 6, 12, 24 hours postoperatively for extraction of the pan-creatic tissues and sampling of the blood from inferior vena cava. This entailed pathological scoring of the pancreas at different time points. Blood amylase was assayed. Apoptosis assay was conducted on the isolated PMN. And the Cas-pase1, 3 and 8 activity was quantified. Results Compared with Sham and ULi group, the levels of blood amylase, histopathological scores of the pancreas and caspase 1 activity were significantly increased, and the PMN apoptotic rate, caspase 3 and 8 activity were markedly lower in SAP group (all P<0.05). Conclusion PMN apoptosis rate may have played an important role in the pathogenesis and prognosis of SAP. Ulinastatin might improve the prognosis of SAP by attenuating the caspase 3 and 8 activity leading to mitigate pancreatic injury.